AGSMART, INC. – Trademark Portfolio

Entity Type: 03

AGSMART, INC. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 5 filings in this category. The portfolio also extends into Class 37 (Building & Construction) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include BI02 SOLUTION, THE BIO2 SOLUTION, and POWERED BY ALGAE APPROVED BY NATURE. The owner is based in Strasburg, CO.

P.O. Box 329

Strasburg, CO 80136

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

AGSMART, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (5 filings)

Scientific and technological services; industrial analysis and research services

37
Building & Construction (2 filings)

Building construction; repair; installation services

Frequently Asked Questions

How many trademarks does AGSMART, INC. have?

AGSMART, INC. has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 cancelled.

What trademark classes does AGSMART, INC. file in?

AGSMART, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 37 (Building & Construction). Class 42 covers scientific and technological services; industrial analysis and research services.

What are AGSMART, INC.'s most well-known trademarks?

AGSMART, INC.'s registered trademark portfolio includes well-known marks such as BI02 SOLUTION, THE BIO2 SOLUTION, and POWERED BY ALGAE APPROVED BY NATURE. These are among 3 currently registered trademarks in the portfolio.

What is AGSMART, INC.'s trademark registration success rate?

AGSMART, INC. has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.